Acumen Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Acumen Wealth Advisors's VRTX Position: Q2 2026 in Review
Acumen Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 7.1% in Q2 2026, buying an estimated $7.98K and bringing the position to 272 shares worth $135K. The position accounts for 0.03% of the portfolio, ranked #113.
Acumen Wealth Advisors first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Acumen Wealth Advisors held 272 shares of Vertex Pharmaceuticals worth $135K as of Q2 2026.
- Acumen Wealth Advisors bought 18 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.98K.
- Vertex Pharmaceuticals made up 0.03% of Acumen Wealth Advisors's portfolio in Q2 2026, its #113 holding.
- Acumen Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Acumen Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.